Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Eliyahu Sharon Kalif

CFO at Teva Pharmaceutical Industries Ltd (TEVA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $20.7M

Reported trades

Filed Stock Type Shares Price Value Since
Jun 16SEC TEVATeva Pharmaceutical Industries Ltd Sell Plan 106,56365,621 held (−62%) $34.10 $3.6M +21.7%
May 18SEC TEVATeva Pharmaceutical Industries Ltd Sell Plan 153,251172,184 held (−47%) $35.61 $5.5M +16.5%
Mar 2SEC TEVATeva Pharmaceutical Industries Ltd Sell Plan 345,81057,478 held (−86%) $33.64 $11.6M +23.4%
  • Sell

    CFO Eliyahu Sharon Kalif sold $3.6M of TEVA at $34.10 — cuts the stake by 62%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Eliyahu Sharon Kalif sold $5.5M of TEVA at $35.61 — cuts the stake by 47%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Eliyahu Sharon Kalif sold $11.6M of TEVA at $33.64 — cuts the stake by 86%; pre-scheduled 10b5-1 plan sale.